HOLX
Hologic, Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 2,
"returned": 2,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "308a60c1-08c2-4343-ba7d-bfb13baec78d",
"title": "Hologic (HOLX) Is Considered a Good Investment by Brokers: Is That True?",
"description": "Based on the average brokerage recommendation (ABR), Hologic (HOLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?",
"keywords": "stock, stocks, investment, investment advice, investing, online trading, online investment, online stock trading, stock market, financial, financial planning, quote, quotes, stock quotes",
"snippet": "This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herei...",
"url": "https://www.zacks.com/stock/news/2272736/hologic-holx-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2272736",
"image_url": "https://staticx-tuner.zacks.com/images/default_article_images/default2.jpg",
"language": "en",
"published_at": "2024-05-13T13:30:09.000000Z",
"source": "zacks.com",
"relevance_score": null,
"entities": [
{
"symbol": "HOLX",
"name": "Hologic, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 41.29279,
"sentiment_score": 0.6908,
"highlights": [
{
"highlight": "<em>Hologic</em> (HOLX) Is Considered a Good Investment by Brokers: Is That True?",
"sentiment": 0.6908,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "b52da133-c130-4203-b764-4a84ff07e9ba",
"title": "Hologic: Women's Health Play Looks Healthier Itself (NASDAQ:HOLX)",
"description": "Hologic recently made another bolt-on acquisition and expects organic sales to grow by 5-7%. Check out what makes HOLX stock an attractive investment.",
"keywords": "",
"snippet": "The Good Brigade\n\nIn February, I believed that shares of Hologic, Inc. (NASDAQ:HOLX) were starting to look a bit more attractive as headwinds were disappearing....",
"url": "https://seekingalpha.com/article/4692693-hologic-womens-health-play-looks-healthier-itself",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1293518316/image_1293518316.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-05-13T07:56:51.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "HOLX",
"name": "Hologic, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 93.81242,
"sentiment_score": 0.29498,
"highlights": [
{
"highlight": "The Good Brigade\n\nIn February, I believed that shares of <em>Hologic</em>, <em>Inc</em>. (<em>NASDAQ:HOLX</em>) were starting to look a bit more attractive as headwinds were disappearing. The women's health business benefited greatly from the pandemic (through its diagnostics business) yet the subsequent headwinds are ending in 2024.",
"sentiment": 0.8055,
"highlighted_in": "main_text"
},
{
"highlight": "Women's Health\n\n<em>Hologic</em> aims to elevate women's health across the globe, as over time it has become a $4 billion business. A substantial diagnostics business makes up for nearly half of sales, complemented by a near 40% breast and skeletal division, with some 15% of sales generated from surgical applications.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Stuck In The Seventies\n\nSince February, shares of <em>Hologic</em> have been tied around the $75 mark, as shares have shown remarkably little volatility. Late in April, <em>Hologic</em> announced a $310 million deal to acquire Endomagnetics, a privately-held breast cancer surgery technology business.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Early in May, <em>Hologic</em> reported a near 1% fall in second quarter sales to $1.02 billion with pandemic related revenues running off, while organic growth comes in close to 5%. The company witnessed some margin contraction, with adjusted earnings down three cents to $1.03 per share.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hologic</em>: Women's Health Play Looks Healthier Itself (<em>NASDAQ:HOLX</em>)",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "HOLX",
"total_documents": 2,
"sentiment_avg": 0.49289000034332275
}
]
}
Other details
Exchange
- NASDAQ Stock Exchange
- equity
- Healthcare
- us